The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis

Caroline A. Heckman(University of Helsinki), Kari Alitalo(University of Helsinki)
Cancer Research
June 15, 2008
Cited by 117


Related Papers